Not applicableStudy completedNCT03309020What this trial is testingPREVAIL VII: Cataract Surgery in Ebola SurvivorsWho this might be right forCataract National Eye Institute (NEI) 37
Not applicableStudy completedNCT02431923What this trial is testingEbola Virus Disease Survivors: Clinical and Immunologic Follow-upWho this might be right forEbola Virus Disease National Institute of Allergy and Infectious Diseases (NIAID) 4,043
Testing effectiveness (Phase 2)Study completedNCT02818582What this trial is testingGS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in SemenWho this might be right forEbola National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Ended earlyNCT02739477What this trial is testingTolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the SemenWho this might be right forEbola Virus Survivor Institut National de la Santé Et de la Recherche Médicale, France 2
Not applicableStudy completedNCT05494801What this trial is testingNatural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL IIIWho this might be right forEbola Virus Disease National Institute of Allergy and Infectious Diseases (NIAID) 203
Post-approval studies (Phase 4)Active Not RecruitingNCT05992480What this trial is testingREVIVE (Response to the Ebola Virus Vaccine)Who this might be right forEbola Virus Disease Tulane University 40
Not applicableStudy completedNCT03098862What this trial is testingPREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine ResponseWho this might be right forEbola Virus Disease National Institute of Allergy and Infectious Diseases (NIAID) 4,830